Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,908
archived clinical trials in
Renal Impairment / Chronic Kidney Disease

Pharmacokinetic and Pharmacodynamic Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes
A Multiple-Dose, Open-Label Pharmakokinetic and Pharmacodynamic Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes
Status: Enrolling
Updated:  5/4/2012
University of Miami School of Medicine
mi
from
Miami, FL
Pharmacokinetic and Pharmacodynamic Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes
A Multiple-Dose, Open-Label Pharmakokinetic and Pharmacodynamic Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes
Status: Enrolling
Updated: 5/4/2012
University of Miami School of Medicine
mi
from
Miami, FL
Click here to add this to my saved trials
Pharmacokinetic and Pharmacodynamic Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes
A Multiple-Dose, Open-Label Pharmakokinetic and Pharmacodynamic Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes
Status: Enrolling
Updated:  5/4/2012
Pacific Renal Research Institute
mi
from
Caldwell, ID
Pharmacokinetic and Pharmacodynamic Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes
A Multiple-Dose, Open-Label Pharmakokinetic and Pharmacodynamic Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes
Status: Enrolling
Updated: 5/4/2012
Pacific Renal Research Institute
mi
from
Caldwell, ID
Click here to add this to my saved trials
Pharmacokinetic and Pharmacodynamic Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes
A Multiple-Dose, Open-Label Pharmakokinetic and Pharmacodynamic Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes
Status: Enrolling
Updated:  5/4/2012
U.T. Southwestern Medical Center
mi
from
Dallas, TX
Pharmacokinetic and Pharmacodynamic Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes
A Multiple-Dose, Open-Label Pharmakokinetic and Pharmacodynamic Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes
Status: Enrolling
Updated: 5/4/2012
U.T. Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Protein Intake, Nutrition and Cardiovascular Diseases in Stage V CKD
Protein Intake, Nutrition and Cardiovascular Disease in Stage V CKD on Hemodialysis
Status: Enrolling
Updated:  5/10/2012
Vanderbilt University Medical Centet
mi
from
Nashville, TN
Protein Intake, Nutrition and Cardiovascular Diseases in Stage V CKD
Protein Intake, Nutrition and Cardiovascular Disease in Stage V CKD on Hemodialysis
Status: Enrolling
Updated: 5/10/2012
Vanderbilt University Medical Centet
mi
from
Nashville, TN
Click here to add this to my saved trials
Protein Intake, Nutrition and Cardiovascular Diseases in Stage V CKD
Protein Intake, Nutrition and Cardiovascular Disease in Stage V CKD on Hemodialysis
Status: Enrolling
Updated:  5/10/2012
University of Utah
mi
from
Salt Lake City, UT
Protein Intake, Nutrition and Cardiovascular Diseases in Stage V CKD
Protein Intake, Nutrition and Cardiovascular Disease in Stage V CKD on Hemodialysis
Status: Enrolling
Updated: 5/10/2012
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Evaluation of CLP With and Without Spironolactone in Heart Failure Patients With Chronic Kidney Disease
A Phase 1, Open-label, Randomized, Crossover Study to Assess the Safety, Tolerability, and Efficacy of CLP With and Without Spironolactone in Adults With Heart Failure
Status: Archived
Updated:  5/11/2012
Orange Country Research Center
mi
from
Tustin, CA
Evaluation of CLP With and Without Spironolactone in Heart Failure Patients With Chronic Kidney Disease
A Phase 1, Open-label, Randomized, Crossover Study to Assess the Safety, Tolerability, and Efficacy of CLP With and Without Spironolactone in Adults With Heart Failure
Status: Archived
Updated: 5/11/2012
Orange Country Research Center
mi
from
Tustin, CA
Telemonitoring to Improve Outcomes of Patients With Chronic Kidney Disease (CKD)
Telemonitoring to Improve Outcomes of Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  5/18/2012
VA Medical Center
mi
from
Minneapolis, MN
Telemonitoring to Improve Outcomes of Patients With Chronic Kidney Disease (CKD)
Telemonitoring to Improve Outcomes of Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 5/18/2012
VA Medical Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Effect of Sodium Concentration of Priming and Rinsing Fluids on Weight Gain
Effect of Sodium Concentration of Priming and Rinsing Fluids on Interdialytic Weight Gain and Blood Pressure in Hemodialysis Patients: a Prospective Pilot Study
Status: Enrolling
Updated:  5/22/2012
Yorkville Dialysis Center
mi
from
New York, NY
Effect of Sodium Concentration of Priming and Rinsing Fluids on Weight Gain
Effect of Sodium Concentration of Priming and Rinsing Fluids on Interdialytic Weight Gain and Blood Pressure in Hemodialysis Patients: a Prospective Pilot Study
Status: Enrolling
Updated: 5/22/2012
Yorkville Dialysis Center
mi
from
New York, NY
Click here to add this to my saved trials
Study Comparing Effects of Lanthanum Carbonate Versus Calcium Acetate Versus Dietary Phosphorus Restriction
Changes in Biochemical and Vascular Parameters w/Lanthanum Carbonate & Calcium Acetate Therapy Compared to Dietary Intervention in Pts w/Stage 3 & 4 Chronic Kidney Disease & Abnormal Phosphorus Homeostasis: a Randomized Controlled Trial
Status: Enrolling
Updated:  6/11/2012
VA Medical Center
mi
from
Salem, VA
Study Comparing Effects of Lanthanum Carbonate Versus Calcium Acetate Versus Dietary Phosphorus Restriction
Changes in Biochemical and Vascular Parameters w/Lanthanum Carbonate & Calcium Acetate Therapy Compared to Dietary Intervention in Pts w/Stage 3 & 4 Chronic Kidney Disease & Abnormal Phosphorus Homeostasis: a Randomized Controlled Trial
Status: Enrolling
Updated: 6/11/2012
VA Medical Center
mi
from
Salem, VA
Click here to add this to my saved trials
Near Infrared Spectroscopy for the Detection of Acute Kidney Injury in Children Following Cardiac Surgery
Use of Near Infrared Spectroscopy (NIRS) for the Early Detection of Acute Kidney Injury in Children Post Cardiopulmonary Bypass
Status: Enrolling
Updated:  6/12/2012
Children's Hospital Colorado
mi
from
Aurora, CO
Near Infrared Spectroscopy for the Detection of Acute Kidney Injury in Children Following Cardiac Surgery
Use of Near Infrared Spectroscopy (NIRS) for the Early Detection of Acute Kidney Injury in Children Post Cardiopulmonary Bypass
Status: Enrolling
Updated: 6/12/2012
Children's Hospital Colorado
mi
from
Aurora, CO
Click here to add this to my saved trials
Adipokines in Hemodialysis Patients
Adipokines in Hemodialysis Patients
Status: Enrolling
Updated:  6/13/2012
University of Colorado Hospital
mi
from
Aurora, CO
Adipokines in Hemodialysis Patients
Adipokines in Hemodialysis Patients
Status: Enrolling
Updated: 6/13/2012
University of Colorado Hospital
mi
from
Aurora, CO
Click here to add this to my saved trials
Adipokines in Hemodialysis Patients
Adipokines in Hemodialysis Patients
Status: Enrolling
Updated:  6/13/2012
University of Utah
mi
from
Salt Lake City, UT
Adipokines in Hemodialysis Patients
Adipokines in Hemodialysis Patients
Status: Enrolling
Updated: 6/13/2012
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Polycystic Liver Disease in Kidney Transplant
Single Center, Open-label Randomized Prospective Trial: Effect of Sirolimus on Polycystic Liver Disease
Status: Enrolling
Updated:  6/18/2012
Mayo Clinic Rochester
mi
from
Rochester, MN
Polycystic Liver Disease in Kidney Transplant
Single Center, Open-label Randomized Prospective Trial: Effect of Sirolimus on Polycystic Liver Disease
Status: Enrolling
Updated: 6/18/2012
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Calcineurin Inhibitor-free, Steroid-free Immunosuppressive Regimen in Simultaneous Islet-Kidney Transplantation for Uremic Type 1 Diabetic Patients
Calcineurin Inhibitor-free, Steroid-free Immunosuppressive Regimen in Simultaneous Islet-Kidney Transplantation for Uremic Type 1 Diabetic Patients
Status: Enrolling
Updated:  6/22/2012
University of Wisconsin
mi
from
Madison, WI
Calcineurin Inhibitor-free, Steroid-free Immunosuppressive Regimen in Simultaneous Islet-Kidney Transplantation for Uremic Type 1 Diabetic Patients
Calcineurin Inhibitor-free, Steroid-free Immunosuppressive Regimen in Simultaneous Islet-Kidney Transplantation for Uremic Type 1 Diabetic Patients
Status: Enrolling
Updated: 6/22/2012
University of Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
Pharmacokinetic, Safety/Tolerability Study of a Single SC Dose of PB1023 Injection in Subjects With Normal and Impaired Renal Function
Phase 1 Open-Label Pharmacokinetic, Safety and Tolerability Study of a Single Subcutaneous Dose of Glymera (PB1023) Injection in Subjects With Normal Renal Function and Subjects With Impaired Renal Function
Status: Enrolling
Updated:  6/26/2012
Prism Research
mi
from
St Paul, MN
Pharmacokinetic, Safety/Tolerability Study of a Single SC Dose of PB1023 Injection in Subjects With Normal and Impaired Renal Function
Phase 1 Open-Label Pharmacokinetic, Safety and Tolerability Study of a Single Subcutaneous Dose of Glymera (PB1023) Injection in Subjects With Normal Renal Function and Subjects With Impaired Renal Function
Status: Enrolling
Updated: 6/26/2012
Prism Research
mi
from
St Paul, MN
Click here to add this to my saved trials
Pharmacokinetic, Safety/Tolerability Study of a Single SC Dose of PB1023 Injection in Subjects With Normal and Impaired Renal Function
Phase 1 Open-Label Pharmacokinetic, Safety and Tolerability Study of a Single Subcutaneous Dose of Glymera (PB1023) Injection in Subjects With Normal Renal Function and Subjects With Impaired Renal Function
Status: Enrolling
Updated:  6/26/2012
New Orleans Center for Clinical Research
mi
from
Knoxville, TN
Pharmacokinetic, Safety/Tolerability Study of a Single SC Dose of PB1023 Injection in Subjects With Normal and Impaired Renal Function
Phase 1 Open-Label Pharmacokinetic, Safety and Tolerability Study of a Single Subcutaneous Dose of Glymera (PB1023) Injection in Subjects With Normal Renal Function and Subjects With Impaired Renal Function
Status: Enrolling
Updated: 6/26/2012
New Orleans Center for Clinical Research
mi
from
Knoxville, TN
Click here to add this to my saved trials
N-Acetylcysteine and Milk Thistle for Treatment of Diabetic Nephropathy
N-Acetylcysteine and Milk Thistle for Treatment of Diabetic Nephropathy.
Status: Enrolling
Updated:  7/10/2012
University of Texas Hlth Sci Ctr San Ant
mi
from
San Antonio, TX
N-Acetylcysteine and Milk Thistle for Treatment of Diabetic Nephropathy
N-Acetylcysteine and Milk Thistle for Treatment of Diabetic Nephropathy.
Status: Enrolling
Updated: 7/10/2012
University of Texas Hlth Sci Ctr San Ant
mi
from
San Antonio, TX
Click here to add this to my saved trials
Fondaparinux in Critically Ill Patients With Renal Failure
Use of Fondaparinux in Critically Ill Patients With Renal Failure
Status: Enrolling
Updated:  7/16/2012
Detroit Medical Center
mi
from
Detroit, MI
Fondaparinux in Critically Ill Patients With Renal Failure
Use of Fondaparinux in Critically Ill Patients With Renal Failure
Status: Enrolling
Updated: 7/16/2012
Detroit Medical Center
mi
from
Detroit, MI
Click here to add this to my saved trials
Safety and Dose Finding Study of Xigris in Hemodialysis Patients
Safety and Dose Finding Study of Xigris (Drotrecogin Alfa Activated) as an Anti-coagulant in End Stage Renal Disease (ESRD) Patients Treated With Hemodialysis (HD)
Status: Enrolling
Updated:  7/20/2012
George Washington University Hospital
mi
from
Washington,
Safety and Dose Finding Study of Xigris in Hemodialysis Patients
Safety and Dose Finding Study of Xigris (Drotrecogin Alfa Activated) as an Anti-coagulant in End Stage Renal Disease (ESRD) Patients Treated With Hemodialysis (HD)
Status: Enrolling
Updated: 7/20/2012
George Washington University Hospital
mi
from
Washington,
Click here to add this to my saved trials
Omega-3 Fatty Acid Administration in Dialysis Patients
Omega-3 Fatty Acid Administration in Dialysis Patients
Status: Enrolling
Updated:  7/23/2012
Vanderbilt University Medical Center
mi
from
Nashville, TN
Omega-3 Fatty Acid Administration in Dialysis Patients
Omega-3 Fatty Acid Administration in Dialysis Patients
Status: Enrolling
Updated: 7/23/2012
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Desensitization of Renal Transplant Candidates
Desensitization of Renal Transplant Candidates
Status: Enrolling
Updated:  7/24/2012
University of Florida
mi
from
Gainesville, FL
Desensitization of Renal Transplant Candidates
Desensitization of Renal Transplant Candidates
Status: Enrolling
Updated: 7/24/2012
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
A Study to Evaluate the Effect of ASP8597 in Adult Kidney Transplant Patients
A Phase 2/3, Double-Blind, Placebo-Controlled, Two-Part Study (Part 1 Open-Label) to Assess the Safety, Efficacy and Pharmacokinetics of Single Intravenous Doses of ASP8597 (Diannexin) in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated:  8/6/2012
St. Vincent Medical Center
mi
from
Los Angeles, CA
A Study to Evaluate the Effect of ASP8597 in Adult Kidney Transplant Patients
A Phase 2/3, Double-Blind, Placebo-Controlled, Two-Part Study (Part 1 Open-Label) to Assess the Safety, Efficacy and Pharmacokinetics of Single Intravenous Doses of ASP8597 (Diannexin) in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated: 8/6/2012
St. Vincent Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study to Evaluate the Effect of ASP8597 in Adult Kidney Transplant Patients
A Phase 2/3, Double-Blind, Placebo-Controlled, Two-Part Study (Part 1 Open-Label) to Assess the Safety, Efficacy and Pharmacokinetics of Single Intravenous Doses of ASP8597 (Diannexin) in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated:  8/6/2012
Sharp Memorial
mi
from
San Diego, CA
A Study to Evaluate the Effect of ASP8597 in Adult Kidney Transplant Patients
A Phase 2/3, Double-Blind, Placebo-Controlled, Two-Part Study (Part 1 Open-Label) to Assess the Safety, Efficacy and Pharmacokinetics of Single Intravenous Doses of ASP8597 (Diannexin) in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated: 8/6/2012
Sharp Memorial
mi
from
San Diego, CA
Click here to add this to my saved trials
A Study to Evaluate the Effect of ASP8597 in Adult Kidney Transplant Patients
A Phase 2/3, Double-Blind, Placebo-Controlled, Two-Part Study (Part 1 Open-Label) to Assess the Safety, Efficacy and Pharmacokinetics of Single Intravenous Doses of ASP8597 (Diannexin) in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated:  8/6/2012
California Pacific Medical Center
mi
from
San Francisco, CA
A Study to Evaluate the Effect of ASP8597 in Adult Kidney Transplant Patients
A Phase 2/3, Double-Blind, Placebo-Controlled, Two-Part Study (Part 1 Open-Label) to Assess the Safety, Efficacy and Pharmacokinetics of Single Intravenous Doses of ASP8597 (Diannexin) in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated: 8/6/2012
California Pacific Medical Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
A Study to Evaluate the Effect of ASP8597 in Adult Kidney Transplant Patients
A Phase 2/3, Double-Blind, Placebo-Controlled, Two-Part Study (Part 1 Open-Label) to Assess the Safety, Efficacy and Pharmacokinetics of Single Intravenous Doses of ASP8597 (Diannexin) in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated:  8/6/2012
University of California at San Francisco
mi
from
San Francisco, CA
A Study to Evaluate the Effect of ASP8597 in Adult Kidney Transplant Patients
A Phase 2/3, Double-Blind, Placebo-Controlled, Two-Part Study (Part 1 Open-Label) to Assess the Safety, Efficacy and Pharmacokinetics of Single Intravenous Doses of ASP8597 (Diannexin) in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated: 8/6/2012
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
A Study to Evaluate the Effect of ASP8597 in Adult Kidney Transplant Patients
A Phase 2/3, Double-Blind, Placebo-Controlled, Two-Part Study (Part 1 Open-Label) to Assess the Safety, Efficacy and Pharmacokinetics of Single Intravenous Doses of ASP8597 (Diannexin) in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated:  8/6/2012
University of Colorado Hospital
mi
from
Aurora, CO
A Study to Evaluate the Effect of ASP8597 in Adult Kidney Transplant Patients
A Phase 2/3, Double-Blind, Placebo-Controlled, Two-Part Study (Part 1 Open-Label) to Assess the Safety, Efficacy and Pharmacokinetics of Single Intravenous Doses of ASP8597 (Diannexin) in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated: 8/6/2012
University of Colorado Hospital
mi
from
Aurora, CO
Click here to add this to my saved trials
A Study to Evaluate the Effect of ASP8597 in Adult Kidney Transplant Patients
A Phase 2/3, Double-Blind, Placebo-Controlled, Two-Part Study (Part 1 Open-Label) to Assess the Safety, Efficacy and Pharmacokinetics of Single Intravenous Doses of ASP8597 (Diannexin) in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated:  8/6/2012
University of Michigan
mi
from
Ann Arbor, MI
A Study to Evaluate the Effect of ASP8597 in Adult Kidney Transplant Patients
A Phase 2/3, Double-Blind, Placebo-Controlled, Two-Part Study (Part 1 Open-Label) to Assess the Safety, Efficacy and Pharmacokinetics of Single Intravenous Doses of ASP8597 (Diannexin) in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated: 8/6/2012
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
A Study to Evaluate the Effect of ASP8597 in Adult Kidney Transplant Patients
A Phase 2/3, Double-Blind, Placebo-Controlled, Two-Part Study (Part 1 Open-Label) to Assess the Safety, Efficacy and Pharmacokinetics of Single Intravenous Doses of ASP8597 (Diannexin) in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated:  8/6/2012
Washington University
mi
from
St. Louis, MO
A Study to Evaluate the Effect of ASP8597 in Adult Kidney Transplant Patients
A Phase 2/3, Double-Blind, Placebo-Controlled, Two-Part Study (Part 1 Open-Label) to Assess the Safety, Efficacy and Pharmacokinetics of Single Intravenous Doses of ASP8597 (Diannexin) in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated: 8/6/2012
Washington University
mi
from
St. Louis, MO
Click here to add this to my saved trials
A Study to Evaluate the Effect of ASP8597 in Adult Kidney Transplant Patients
A Phase 2/3, Double-Blind, Placebo-Controlled, Two-Part Study (Part 1 Open-Label) to Assess the Safety, Efficacy and Pharmacokinetics of Single Intravenous Doses of ASP8597 (Diannexin) in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated:  8/6/2012
St. Barnabas Medical Center
mi
from
Livingston, NJ
A Study to Evaluate the Effect of ASP8597 in Adult Kidney Transplant Patients
A Phase 2/3, Double-Blind, Placebo-Controlled, Two-Part Study (Part 1 Open-Label) to Assess the Safety, Efficacy and Pharmacokinetics of Single Intravenous Doses of ASP8597 (Diannexin) in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated: 8/6/2012
St. Barnabas Medical Center
mi
from
Livingston, NJ
Click here to add this to my saved trials
A Study to Evaluate the Effect of ASP8597 in Adult Kidney Transplant Patients
A Phase 2/3, Double-Blind, Placebo-Controlled, Two-Part Study (Part 1 Open-Label) to Assess the Safety, Efficacy and Pharmacokinetics of Single Intravenous Doses of ASP8597 (Diannexin) in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated:  8/6/2012
Montefiore Medical Center
mi
from
Bronx, NY
A Study to Evaluate the Effect of ASP8597 in Adult Kidney Transplant Patients
A Phase 2/3, Double-Blind, Placebo-Controlled, Two-Part Study (Part 1 Open-Label) to Assess the Safety, Efficacy and Pharmacokinetics of Single Intravenous Doses of ASP8597 (Diannexin) in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated: 8/6/2012
Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
A Study to Evaluate the Effect of ASP8597 in Adult Kidney Transplant Patients
A Phase 2/3, Double-Blind, Placebo-Controlled, Two-Part Study (Part 1 Open-Label) to Assess the Safety, Efficacy and Pharmacokinetics of Single Intravenous Doses of ASP8597 (Diannexin) in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated:  8/6/2012
New York Presbyterian Hospital
mi
from
White Plains, NY
A Study to Evaluate the Effect of ASP8597 in Adult Kidney Transplant Patients
A Phase 2/3, Double-Blind, Placebo-Controlled, Two-Part Study (Part 1 Open-Label) to Assess the Safety, Efficacy and Pharmacokinetics of Single Intravenous Doses of ASP8597 (Diannexin) in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated: 8/6/2012
New York Presbyterian Hospital
mi
from
White Plains, NY
Click here to add this to my saved trials
A Study to Evaluate the Effect of ASP8597 in Adult Kidney Transplant Patients
A Phase 2/3, Double-Blind, Placebo-Controlled, Two-Part Study (Part 1 Open-Label) to Assess the Safety, Efficacy and Pharmacokinetics of Single Intravenous Doses of ASP8597 (Diannexin) in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated:  8/6/2012
Carolinas Medical Center
mi
from
Charlotte, NC
A Study to Evaluate the Effect of ASP8597 in Adult Kidney Transplant Patients
A Phase 2/3, Double-Blind, Placebo-Controlled, Two-Part Study (Part 1 Open-Label) to Assess the Safety, Efficacy and Pharmacokinetics of Single Intravenous Doses of ASP8597 (Diannexin) in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated: 8/6/2012
Carolinas Medical Center
mi
from
Charlotte, NC
Click here to add this to my saved trials
A Study to Evaluate the Effect of ASP8597 in Adult Kidney Transplant Patients
A Phase 2/3, Double-Blind, Placebo-Controlled, Two-Part Study (Part 1 Open-Label) to Assess the Safety, Efficacy and Pharmacokinetics of Single Intravenous Doses of ASP8597 (Diannexin) in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated:  8/6/2012
Duke University
mi
from
Durham, NC
A Study to Evaluate the Effect of ASP8597 in Adult Kidney Transplant Patients
A Phase 2/3, Double-Blind, Placebo-Controlled, Two-Part Study (Part 1 Open-Label) to Assess the Safety, Efficacy and Pharmacokinetics of Single Intravenous Doses of ASP8597 (Diannexin) in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated: 8/6/2012
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
A Study to Evaluate the Effect of ASP8597 in Adult Kidney Transplant Patients
A Phase 2/3, Double-Blind, Placebo-Controlled, Two-Part Study (Part 1 Open-Label) to Assess the Safety, Efficacy and Pharmacokinetics of Single Intravenous Doses of ASP8597 (Diannexin) in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated:  8/6/2012
East Carolina University
mi
from
Greenville, NC
A Study to Evaluate the Effect of ASP8597 in Adult Kidney Transplant Patients
A Phase 2/3, Double-Blind, Placebo-Controlled, Two-Part Study (Part 1 Open-Label) to Assess the Safety, Efficacy and Pharmacokinetics of Single Intravenous Doses of ASP8597 (Diannexin) in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated: 8/6/2012
East Carolina University
mi
from
Greenville, NC
Click here to add this to my saved trials
A Study to Evaluate the Effect of ASP8597 in Adult Kidney Transplant Patients
A Phase 2/3, Double-Blind, Placebo-Controlled, Two-Part Study (Part 1 Open-Label) to Assess the Safety, Efficacy and Pharmacokinetics of Single Intravenous Doses of ASP8597 (Diannexin) in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated:  8/6/2012
Pinnacle Health at Harrisburg
mi
from
Harrisburg, PA
A Study to Evaluate the Effect of ASP8597 in Adult Kidney Transplant Patients
A Phase 2/3, Double-Blind, Placebo-Controlled, Two-Part Study (Part 1 Open-Label) to Assess the Safety, Efficacy and Pharmacokinetics of Single Intravenous Doses of ASP8597 (Diannexin) in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated: 8/6/2012
Pinnacle Health at Harrisburg
mi
from
Harrisburg, PA
Click here to add this to my saved trials
A Study to Evaluate the Effect of ASP8597 in Adult Kidney Transplant Patients
A Phase 2/3, Double-Blind, Placebo-Controlled, Two-Part Study (Part 1 Open-Label) to Assess the Safety, Efficacy and Pharmacokinetics of Single Intravenous Doses of ASP8597 (Diannexin) in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated:  8/6/2012
Baylor University Medical Center
mi
from
Dallas, TX
A Study to Evaluate the Effect of ASP8597 in Adult Kidney Transplant Patients
A Phase 2/3, Double-Blind, Placebo-Controlled, Two-Part Study (Part 1 Open-Label) to Assess the Safety, Efficacy and Pharmacokinetics of Single Intravenous Doses of ASP8597 (Diannexin) in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated: 8/6/2012
Baylor University Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study to Evaluate the Effect of ASP8597 in Adult Kidney Transplant Patients
A Phase 2/3, Double-Blind, Placebo-Controlled, Two-Part Study (Part 1 Open-Label) to Assess the Safety, Efficacy and Pharmacokinetics of Single Intravenous Doses of ASP8597 (Diannexin) in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated:  8/6/2012
Baylor All Saints Medical Center
mi
from
Fort Worth, TX
A Study to Evaluate the Effect of ASP8597 in Adult Kidney Transplant Patients
A Phase 2/3, Double-Blind, Placebo-Controlled, Two-Part Study (Part 1 Open-Label) to Assess the Safety, Efficacy and Pharmacokinetics of Single Intravenous Doses of ASP8597 (Diannexin) in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated: 8/6/2012
Baylor All Saints Medical Center
mi
from
Fort Worth, TX
Click here to add this to my saved trials
A Study to Evaluate the Effect of ASP8597 in Adult Kidney Transplant Patients
A Phase 2/3, Double-Blind, Placebo-Controlled, Two-Part Study (Part 1 Open-Label) to Assess the Safety, Efficacy and Pharmacokinetics of Single Intravenous Doses of ASP8597 (Diannexin) in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated:  8/6/2012
Houston Methodist Hospital
mi
from
Houston, TX
A Study to Evaluate the Effect of ASP8597 in Adult Kidney Transplant Patients
A Phase 2/3, Double-Blind, Placebo-Controlled, Two-Part Study (Part 1 Open-Label) to Assess the Safety, Efficacy and Pharmacokinetics of Single Intravenous Doses of ASP8597 (Diannexin) in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated: 8/6/2012
Houston Methodist Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
A Study to Evaluate the Effect of ASP8597 in Adult Kidney Transplant Patients
A Phase 2/3, Double-Blind, Placebo-Controlled, Two-Part Study (Part 1 Open-Label) to Assess the Safety, Efficacy and Pharmacokinetics of Single Intravenous Doses of ASP8597 (Diannexin) in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated:  8/6/2012
University of Virginia
mi
from
Charlottesville, VA
A Study to Evaluate the Effect of ASP8597 in Adult Kidney Transplant Patients
A Phase 2/3, Double-Blind, Placebo-Controlled, Two-Part Study (Part 1 Open-Label) to Assess the Safety, Efficacy and Pharmacokinetics of Single Intravenous Doses of ASP8597 (Diannexin) in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated: 8/6/2012
University of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials
A Study to Evaluate the Effect of ASP8597 in Adult Kidney Transplant Patients
A Phase 2/3, Double-Blind, Placebo-Controlled, Two-Part Study (Part 1 Open-Label) to Assess the Safety, Efficacy and Pharmacokinetics of Single Intravenous Doses of ASP8597 (Diannexin) in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated:  8/6/2012
University of Wisconsin
mi
from
Madison, WI
A Study to Evaluate the Effect of ASP8597 in Adult Kidney Transplant Patients
A Phase 2/3, Double-Blind, Placebo-Controlled, Two-Part Study (Part 1 Open-Label) to Assess the Safety, Efficacy and Pharmacokinetics of Single Intravenous Doses of ASP8597 (Diannexin) in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated: 8/6/2012
University of Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Status: Enrolling
Updated:  8/8/2012
LA County/USC Medical Center
mi
from
Los Angeles, CA
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Status: Enrolling
Updated: 8/8/2012
LA County/USC Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Status: Enrolling
Updated:  8/8/2012
University of California, San Diego
mi
from
San Diego, CA
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Status: Enrolling
Updated: 8/8/2012
University of California, San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Status: Enrolling
Updated:  8/8/2012
UC San Francisco General Hospital
mi
from
San Francisco, CA
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Status: Enrolling
Updated: 8/8/2012
UC San Francisco General Hospital
mi
from
San Francisco, CA
Click here to add this to my saved trials
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Status: Enrolling
Updated:  8/8/2012
St. Francis Sleep Allergy and Lungs
mi
from
Clearwater, FL
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Status: Enrolling
Updated: 8/8/2012
St. Francis Sleep Allergy and Lungs
mi
from
Clearwater, FL
Click here to add this to my saved trials
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Status: Enrolling
Updated:  8/8/2012
Queen's Medical Center
mi
from
Honolulu, HI
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Status: Enrolling
Updated: 8/8/2012
Queen's Medical Center
mi
from
Honolulu, HI
Click here to add this to my saved trials
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Status: Enrolling
Updated:  8/8/2012
Northwestern University Feinberg School of Medicine
mi
from
Chicago, IL
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Status: Enrolling
Updated: 8/8/2012
Northwestern University Feinberg School of Medicine
mi
from
Chicago, IL
Click here to add this to my saved trials
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Status: Enrolling
Updated:  8/8/2012
Kansas University Medical Center
mi
from
Kansas City, KA
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Status: Enrolling
Updated: 8/8/2012
Kansas University Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Status: Enrolling
Updated:  8/8/2012
University of Maryland Medical Center
mi
from
Baltimore, MD
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Status: Enrolling
Updated: 8/8/2012
University of Maryland Medical Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Status: Enrolling
Updated:  8/8/2012
Henry Ford Hospital
mi
from
Detroit, MI
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Status: Enrolling
Updated: 8/8/2012
Henry Ford Hospital
mi
from
Detroit, MI
Click here to add this to my saved trials
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Status: Enrolling
Updated:  8/8/2012
Cardiac and Vascular Research Center of Northern Michigan
mi
from
Petoskey, MI
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Status: Enrolling
Updated: 8/8/2012
Cardiac and Vascular Research Center of Northern Michigan
mi
from
Petoskey, MI
Click here to add this to my saved trials